Could Psychedelics Change the Future of Chronic Pain Treatment?
As Australia looks back on National Pain Week, held from 26–31 July, attention remains focused on one of the country's ...
As Australia looks back on National Pain Week, held from 26–31 July, attention remains focused on one of the country's ...
As psychedelic-assisted therapy moves from research into clinical practice in Australia, the organisations building the infrastructure around the sector are ...
A growing body of research has suggested that meditation and psychedelic medicines may share more in common than previously believed. ...
BLS Pharmaceuticals (ASX: BLS) has signed a referral agreement with US-based Cayman Chemical Company, expanding its international commercial network for ...
Medicinal cannabis and psychedelic medicine are often discussed as part of the same healthcare revolution. Both involve substances that spent ...
Compass Pathways has reported positive six-month results from its second Phase 3 clinical trial evaluating COMP360 psilocybin treatment for treatment-resistant ...
Red Light Holland subsidiary Filament Health will supply its naturally derived psilocybin drug candidate, PEX010, for a new clinical trial ...
As psychedelic medicine edges closer to mainstream clinical practice, Europe is approaching a pivotal moment that could shape the sector ...
Canadian pharmaceutical manufacturer Optimi Health has completed a commercial export of GMP-grade psilocybin capsules to Australia under the Therapeutic Goods ...
Psychedelics.media delivers trusted news, intelligence, and insights for the global psychedelic medicine industry.
